COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,890,056 | -5.3% | 129,309 | -9.0% | 0.00% | 0.0% |
Q2 2023 | $3,052,053 | -19.7% | 142,022 | -10.3% | 0.00% | -33.3% |
Q1 2023 | $3,800,376 | +8.2% | 158,415 | +4.6% | 0.00% | 0.0% |
Q4 2022 | $3,513,942 | +54.9% | 151,463 | +7.0% | 0.00% | +50.0% |
Q3 2022 | $2,268,000 | -23.4% | 141,580 | -15.2% | 0.00% | -33.3% |
Q2 2022 | $2,959,000 | -13.0% | 166,977 | -0.1% | 0.00% | 0.0% |
Q1 2022 | $3,402,000 | +15.1% | 167,085 | +5.6% | 0.00% | +50.0% |
Q4 2021 | $2,956,000 | -19.9% | 158,235 | -15.4% | 0.00% | -33.3% |
Q3 2021 | $3,690,000 | -19.3% | 186,942 | -3.3% | 0.00% | -40.0% |
Q2 2021 | $4,571,000 | -1.3% | 193,374 | -1.0% | 0.01% | 0.0% |
Q1 2021 | $4,629,000 | +19.0% | 195,335 | +0.6% | 0.01% | 0.0% |
Q4 2020 | $3,889,000 | -6.6% | 194,154 | -2.9% | 0.01% | -28.6% |
Q3 2020 | $4,163,000 | +12.4% | 199,934 | -5.6% | 0.01% | +16.7% |
Q2 2020 | $3,705,000 | +6.4% | 211,688 | -0.8% | 0.01% | -25.0% |
Q1 2020 | $3,483,000 | -20.9% | 213,310 | -0.3% | 0.01% | 0.0% |
Q4 2019 | $4,405,000 | +84.4% | 214,022 | +2.8% | 0.01% | +60.0% |
Q3 2019 | $2,389,000 | -12.7% | 208,101 | -0.1% | 0.01% | -16.7% |
Q2 2019 | $2,738,000 | -8.9% | 208,232 | +4.9% | 0.01% | -14.3% |
Q1 2019 | $3,004,000 | -12.5% | 198,424 | -0.8% | 0.01% | -22.2% |
Q4 2018 | $3,435,000 | +16.0% | 200,043 | -0.4% | 0.01% | +28.6% |
Q3 2018 | $2,961,000 | -35.4% | 200,863 | +4.5% | 0.01% | -41.7% |
Q2 2018 | $4,586,000 | +12.6% | 192,305 | +20.6% | 0.01% | +9.1% |
Q1 2018 | $4,074,000 | +46.1% | 159,456 | +5.5% | 0.01% | +37.5% |
Q4 2017 | $2,789,000 | +87.2% | 151,085 | +6.4% | 0.01% | +60.0% |
Q3 2017 | $1,490,000 | -16.3% | 142,003 | -0.2% | 0.01% | -28.6% |
Q2 2017 | $1,781,000 | +51.8% | 142,336 | +18.8% | 0.01% | -12.5% |
Q1 2017 | $1,173,000 | -37.0% | 119,801 | +0.9% | 0.01% | -42.9% |
Q4 2016 | $1,861,000 | -22.3% | 118,703 | -0.3% | 0.01% | -39.1% |
Q3 2016 | $2,396,000 | +100.0% | 119,071 | +24.2% | 0.02% | +130.0% |
Q2 2016 | $1,198,000 | -39.1% | 95,898 | -11.4% | 0.01% | +100.0% |
Q1 2016 | $1,968,000 | +56.2% | 108,290 | +105.9% | 0.01% | +66.7% |
Q4 2015 | $1,260,000 | – | 52,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |